首页> 外国专利> Stabilized expression vectors containing lambda pl promoter and the gene for the CI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods

Stabilized expression vectors containing lambda pl promoter and the gene for the CI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods

机译:含有λp1启动子和CI434阻抑子基因的稳定表达载体,含有该载体的质粒,含有该质粒的宿主和相关方法

摘要

An improved vector upon introduction into a suitable host containing the thermolabile repressor C.sub.I renders the host capable of effecting expression of a desired gene. The vector is a double-stranded DNA molecule which includes in 5' to 3' order the following: the promoter and operator P.sub.L O.sub.L from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal bindig site; an ATG initiation codon or DNA which is converted into an ATG initiation codon upon insertion of the desired gene into the vector; a second restriction enzyme site for inserting the gene in phase with the ATG codon; a T.sub.1 T.sub.2 rRNA transcription termination sequence; an origin of replication; and a fragment designated CI.sup.434 on which is included the gene for the repressor protein and its associated promoter and operator. Additionally, the vector may include a gene associated with a selectable or identifiable phenotypic trait which is manifested when the vector is present in the host. The distance between the 3' end of P. sub.L O.sub.L and the 5' end of the N utilization site is less than about 80 base pairs. The distance between the 3' end of the N utilization site and the 5' end of the ribosomal binding site is less than about 300 base pairs. Plasmids have been constructed from the vectors and used to produce bovine growth hormones.
机译:引入含有热不稳定性阻遏物C1的合适宿主中的改进载体使宿主能够实现所需基因的表达。载体是双链DNA分子,其以5'至3'顺序包括以下:来自λ噬菌体的启动子和操纵子PLOL; N利用地点;第一限制性酶切位点,其允许随后取代核糖体结合位点;核糖体结合位点; ATG起始密码子或DNA,其在将所需基因插入载体后转化为ATG起始密码子;第二个限制性酶切位点,用于插入与ATG密码子同相的基因; T.sub.1 T.sub.2 rRNA转录终止序列;复制的起源;片段称为CI 434,其上包含阻遏蛋白的基因及其相关的启动子和操纵子。另外,载体可以包括与可选择的或可识别的表型性状相关的基因,该基因在载体存在于宿主中时表现出来。 P.L O.L的3'端与N利用位点的5'端之间的距离小于约80个碱基对。 N利用位点的3'端与核糖体结合位点的5'端之间的距离小于约300个碱基对。从载体构建了质粒,并用于产生牛生长激素。

著录项

  • 公开/公告号US5147789A

    专利类型

  • 公开/公告日1992-09-15

    原文格式PDF

  • 申请/专利权人 BIO-TECHNOLOGY GENERAL CORP.;

    申请/专利号US19910780353

  • 发明设计人 HILLA LOCKER-GILADI;AMOS B. OPPENHEIM;

    申请日1991-10-22

  • 分类号C12P21/02;C12N15/70;C12N15/73;C12N1/21;

  • 国家 US

  • 入库时间 2022-08-22 05:22:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号